Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Carien L. Creutzberg"'
Autor:
Wiltink LM; Lisette M. Wiltink, Remi A. Nout, Marta Fiocco, Carien L. Creutzberg, and Cornelia A.M. Marijnen, Leiden University Medical Center, Leiden, the Netherlands., Nout RA; Lisette M. Wiltink, Remi A. Nout, Marta Fiocco, Carien L. Creutzberg, and Cornelia A.M. Marijnen, Leiden University Medical Center, Leiden, the Netherlands., Fiocco M; Lisette M. Wiltink, Remi A. Nout, Marta Fiocco, Carien L. Creutzberg, and Cornelia A.M. Marijnen, Leiden University Medical Center, Leiden, the Netherlands., Creutzberg CL; Lisette M. Wiltink, Remi A. Nout, Marta Fiocco, Carien L. Creutzberg, and Cornelia A.M. Marijnen, Leiden University Medical Center, Leiden, the Netherlands., Marijnen CAM; Lisette M. Wiltink, Remi A. Nout, Marta Fiocco, Carien L. Creutzberg, and Cornelia A.M. Marijnen, Leiden University Medical Center, Leiden, the Netherlands.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2017 Jun 01; Vol. 35 (16), pp. 1862. Date of Electronic Publication: 2017 Mar 13.
Autor:
Wiltink LM; Lisette M. Wiltink, Remi A. Nout, Marta Fiocco, Elma Meershoek-Klein Kranenbarg, Cornelis J.H. van de Velde, Carien L. Creutzberg, and Corrie A.M. Marijnen, Leiden University Medical Center, Leiden; Ina M. Jürgenliemk-Schulz, University Medical Center Utrecht, Utrecht; Jan J. Jobsen, Medisch Spectum Twente, Enschede; Iris D. Nagtegaal, Radboud University Medical Center, Nijmegen; and Harm J.T. Rutten, Catharina Hospital Eindhoven, Eindhoven, the Netherlands., Nout RA; Lisette M. Wiltink, Remi A. Nout, Marta Fiocco, Elma Meershoek-Klein Kranenbarg, Cornelis J.H. van de Velde, Carien L. Creutzberg, and Corrie A.M. Marijnen, Leiden University Medical Center, Leiden; Ina M. Jürgenliemk-Schulz, University Medical Center Utrecht, Utrecht; Jan J. Jobsen, Medisch Spectum Twente, Enschede; Iris D. Nagtegaal, Radboud University Medical Center, Nijmegen; and Harm J.T. Rutten, Catharina Hospital Eindhoven, Eindhoven, the Netherlands., Fiocco M; Lisette M. Wiltink, Remi A. Nout, Marta Fiocco, Elma Meershoek-Klein Kranenbarg, Cornelis J.H. van de Velde, Carien L. Creutzberg, and Corrie A.M. Marijnen, Leiden University Medical Center, Leiden; Ina M. Jürgenliemk-Schulz, University Medical Center Utrecht, Utrecht; Jan J. Jobsen, Medisch Spectum Twente, Enschede; Iris D. Nagtegaal, Radboud University Medical Center, Nijmegen; and Harm J.T. Rutten, Catharina Hospital Eindhoven, Eindhoven, the Netherlands., Meershoek-Klein Kranenbarg E; Lisette M. Wiltink, Remi A. Nout, Marta Fiocco, Elma Meershoek-Klein Kranenbarg, Cornelis J.H. van de Velde, Carien L. Creutzberg, and Corrie A.M. Marijnen, Leiden University Medical Center, Leiden; Ina M. Jürgenliemk-Schulz, University Medical Center Utrecht, Utrecht; Jan J. Jobsen, Medisch Spectum Twente, Enschede; Iris D. Nagtegaal, Radboud University Medical Center, Nijmegen; and Harm J.T. Rutten, Catharina Hospital Eindhoven, Eindhoven, the Netherlands., Jürgenliemk-Schulz IM; Lisette M. Wiltink, Remi A. Nout, Marta Fiocco, Elma Meershoek-Klein Kranenbarg, Cornelis J.H. van de Velde, Carien L. Creutzberg, and Corrie A.M. Marijnen, Leiden University Medical Center, Leiden; Ina M. Jürgenliemk-Schulz, University Medical Center Utrecht, Utrecht; Jan J. Jobsen, Medisch Spectum Twente, Enschede; Iris D. Nagtegaal, Radboud University Medical Center, Nijmegen; and Harm J.T. Rutten, Catharina Hospital Eindhoven, Eindhoven, the Netherlands., Jobsen JJ; Lisette M. Wiltink, Remi A. Nout, Marta Fiocco, Elma Meershoek-Klein Kranenbarg, Cornelis J.H. van de Velde, Carien L. Creutzberg, and Corrie A.M. Marijnen, Leiden University Medical Center, Leiden; Ina M. Jürgenliemk-Schulz, University Medical Center Utrecht, Utrecht; Jan J. Jobsen, Medisch Spectum Twente, Enschede; Iris D. Nagtegaal, Radboud University Medical Center, Nijmegen; and Harm J.T. Rutten, Catharina Hospital Eindhoven, Eindhoven, the Netherlands., Nagtegaal ID; Lisette M. Wiltink, Remi A. Nout, Marta Fiocco, Elma Meershoek-Klein Kranenbarg, Cornelis J.H. van de Velde, Carien L. Creutzberg, and Corrie A.M. Marijnen, Leiden University Medical Center, Leiden; Ina M. Jürgenliemk-Schulz, University Medical Center Utrecht, Utrecht; Jan J. Jobsen, Medisch Spectum Twente, Enschede; Iris D. Nagtegaal, Radboud University Medical Center, Nijmegen; and Harm J.T. Rutten, Catharina Hospital Eindhoven, Eindhoven, the Netherlands., Rutten HJ; Lisette M. Wiltink, Remi A. Nout, Marta Fiocco, Elma Meershoek-Klein Kranenbarg, Cornelis J.H. van de Velde, Carien L. Creutzberg, and Corrie A.M. Marijnen, Leiden University Medical Center, Leiden; Ina M. Jürgenliemk-Schulz, University Medical Center Utrecht, Utrecht; Jan J. Jobsen, Medisch Spectum Twente, Enschede; Iris D. Nagtegaal, Radboud University Medical Center, Nijmegen; and Harm J.T. Rutten, Catharina Hospital Eindhoven, Eindhoven, the Netherlands., van de Velde CJ; Lisette M. Wiltink, Remi A. Nout, Marta Fiocco, Elma Meershoek-Klein Kranenbarg, Cornelis J.H. van de Velde, Carien L. Creutzberg, and Corrie A.M. Marijnen, Leiden University Medical Center, Leiden; Ina M. Jürgenliemk-Schulz, University Medical Center Utrecht, Utrecht; Jan J. Jobsen, Medisch Spectum Twente, Enschede; Iris D. Nagtegaal, Radboud University Medical Center, Nijmegen; and Harm J.T. Rutten, Catharina Hospital Eindhoven, Eindhoven, the Netherlands., Creutzberg CL; Lisette M. Wiltink, Remi A. Nout, Marta Fiocco, Elma Meershoek-Klein Kranenbarg, Cornelis J.H. van de Velde, Carien L. Creutzberg, and Corrie A.M. Marijnen, Leiden University Medical Center, Leiden; Ina M. Jürgenliemk-Schulz, University Medical Center Utrecht, Utrecht; Jan J. Jobsen, Medisch Spectum Twente, Enschede; Iris D. Nagtegaal, Radboud University Medical Center, Nijmegen; and Harm J.T. Rutten, Catharina Hospital Eindhoven, Eindhoven, the Netherlands., Marijnen CA; Lisette M. Wiltink, Remi A. Nout, Marta Fiocco, Elma Meershoek-Klein Kranenbarg, Cornelis J.H. van de Velde, Carien L. Creutzberg, and Corrie A.M. Marijnen, Leiden University Medical Center, Leiden; Ina M. Jürgenliemk-Schulz, University Medical Center Utrecht, Utrecht; Jan J. Jobsen, Medisch Spectum Twente, Enschede; Iris D. Nagtegaal, Radboud University Medical Center, Nijmegen; and Harm J.T. Rutten, Catharina Hospital Eindhoven, Eindhoven, the Netherlands. marijnen@lumc.nl.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2015 May 20; Vol. 33 (15), pp. 1640-6. Date of Electronic Publication: 2014 Dec 22.
Autor:
Cornelis D. de Kroon, Annerie Slot, Jannet C. Beukema, Tanja C. Stam, Judith R. Kroep, Hetty A. van den Berg, Ina M. Jürgenliemk-Schulz, Cathalijne C.B. Post, Jan Willem M. Mens, Ludy C.H.W. Lutgens, F. Koppe, Marie A.D. Haverkort, Ellen M.A. Roeloffzen, An Snyers, Carien L. Creutzberg, Eva E. Schaake, Anne M. Stiggelbout, Hans W. Nijman
Publikováno v:
Gynecologic Oncology, 161(3), 727-733
Gynecologic Oncology, 161(3), 727-733. ACADEMIC PRESS INC ELSEVIER SCIENCE
Gynecologic Oncology, 161(3), 727-733. Academic Press
Gynecologic Oncology, 161, 727-733
Gynecologic Oncology, 161(3), 727-733. Elsevier Science
Gynecologic Oncology, 161, 3, pp. 727-733
Gynecologic Oncology, 161(3), 727-733. ACADEMIC PRESS INC ELSEVIER SCIENCE
Gynecologic Oncology, 161(3), 727-733. Academic Press
Gynecologic Oncology, 161, 727-733
Gynecologic Oncology, 161(3), 727-733. Elsevier Science
Gynecologic Oncology, 161, 3, pp. 727-733
Background. Decision making regarding adjuvant therapy for high-risk endometrial cancer is complex. The aim of this study was to determine patients' and clinicians' minimally desired survival benefit to choose chemoradiotherapy over radiotherapy alon
Autor:
Lisa Vermij, Alicia Léon-Castillo, Naveena Singh, Melanie E. Powell, Richard J. Edmondson, Catherine Genestie, Pearly Khaw, Jan Pyman, C. Meg McLachlin, Prafull Ghatage, Stephanie M. de Boer, Hans W. Nijman, Vincent T.H.B.M. Smit, Emma J. Crosbie, Alexandra Leary, Carien L. Creutzberg, Nanda Horeweg, Tjalling Bosse, N. Horeweg, S.M. de Boer, C.L. Creutzberg, T. Bosse, V.T.H.B.M. Smit, J. Kroep, R.A. Nout, H.W. Nijman, M. de Bruyn, M.E. Powell, N. Singh, H.C. Kitchener, E. Crosbie, R. Edmondson, D.N. Church, A. Leary, L. Mileshkin, P.M. Pollock, H. MacKay
Publikováno v:
Modern Pathology, 35(10), 1475-1483. SPRINGERNATURE
Modern Pathology, 35(10), 1475-1483. Nature Publishing Group
TransPORTEC consortium 2022, ' p53 immunohistochemistry in endometrial cancer: clinical and molecular correlates in the PORTEC-3 trial ', Modern Pathology . https://doi.org/10.1038/s41379-022-01102-x
Modern Pathology. Nature Publishing Group
Modern Pathology, 35(10), 1475-1483. Nature Publishing Group
TransPORTEC consortium 2022, ' p53 immunohistochemistry in endometrial cancer: clinical and molecular correlates in the PORTEC-3 trial ', Modern Pathology . https://doi.org/10.1038/s41379-022-01102-x
Modern Pathology. Nature Publishing Group
Standard molecular classification of endometrial cancers (EC) is now endorsed by the WHO and identifies p53-abnormal (p53abn) EC as the subgroup with the poorest prognosis and the most likely to benefit from adjuvant chemo(radio)therapy. P53abn EC ar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::081e838f95f1846415ec67f616f3afc4
https://hdl.handle.net/1887/3505651
https://hdl.handle.net/1887/3505651
Autor:
Nanda, Horeweg, Hagma H, Workel, Dominik, Loiero, David N, Church, Lisa, Vermij, Alicia, Léon-Castillo, Ricki T, Krog, Stephanie M, de Boer, Remi A, Nout, Melanie E, Powell, Linda R, Mileshkin, Helen, MacKay, Alexandra, Leary, Naveena, Singh, Ina M, Jürgenliemk-Schulz, Vincent T H B M, Smit, Carien L, Creutzberg, Viktor H, Koelzer, Hans W, Nijman, Tjalling, Bosse, Marco, de Bruyn
Publikováno v:
Nature Communications, 13(1). NATURE PORTFOLIO
Nature Communications, 13(1):1373. Nature Publishing Group
Nature Communications, 13(1):1373. Nature Publishing Group
B-cells play a key role in cancer suppression, particularly when aggregated in tertiary lymphoid structures (TLS). Here, we investigate the role of B-cells and TLS in endometrial cancer (EC). Single cell RNA-sequencing of B-cells shows presence of na
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc451013e20a5bae0c2ad465678c4abe
http://hdl.handle.net/1887/3281916
http://hdl.handle.net/1887/3281916
Autor:
Nanda Horeweg, Stefan Kommoss, Ludy C.H.W. Lutgens, Katrien Vandecasteele, Marlies E. Nowee, Remi A. Nout, C. Gillham, Bastiaan G Wortman, F. Koppe, Hetty A. van den Berg, Tjalling Bosse, David Cibula, Karen W Verhoeven-Adema, Annerie Slot, Hein Putter, Cyrus Chargari, Ina M. Jürgenliemk-Schulz, Veronique L M A Coen, Aleida G Zwanenburg, Hans W. Nijman, Carien L. Creutzberg, Elzbieta van der Steen-Banasik, Tanja C. Stam, G Henrieke Westerveld, Anne Sophie V M van den Heerik, Wilbert B. van den Hout, Jan Willem M. Mens, An Snyers, Moritz Hamann, Stefan Bijmolt
Publikováno v:
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2020(30), 2002-2007. BMJ Publishing Group
International journal of gynecological cancer, 30(12), 2002-2007. Wolters Kluwer Health
International Journal of Gynecological Cancer, 30, 12, pp. 2002-2007
International Journal of Gynecological Cancer, 30(12), 2002-2007. BMJ Publishing Group
International Journal of Gynecological Cancer
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
International Journal of Gynecological Cancer, 30, 2002-2007
International Journal of Gynecological Cancer, 30(12), 2002-2007. LIPPINCOTT WILLIAMS & WILKINS
International journal of gynecological cancer, 30(12), 2002-2007. Wolters Kluwer Health
International Journal of Gynecological Cancer, 30, 12, pp. 2002-2007
International Journal of Gynecological Cancer, 30(12), 2002-2007. BMJ Publishing Group
International Journal of Gynecological Cancer
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
International Journal of Gynecological Cancer, 30, 2002-2007
International Journal of Gynecological Cancer, 30(12), 2002-2007. LIPPINCOTT WILLIAMS & WILKINS
BackgroundVaginal brachytherapy is currently recommended as adjuvant treatment in patients with high-intermediate risk endometrial cancer to maximize local control and has only mild side effects and no or limited impact on quality of life. However, t
Autor:
Tjalling Bosse, Stephanie M. de Boer, Carien L. Creutzberg, Nanda Horeweg, Anne Sophie V M van den Heerik
Publikováno v:
International Journal of Gynecological Cancer, 31(4), 594-604. BMJ PUBLISHING GROUP
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2021(34), 594-604. BMJ Publishing Group
International Journal of Gynecological Cancer
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2021(34), 594-604. BMJ Publishing Group
International Journal of Gynecological Cancer
Endometrial cancer is primarily treated with surgery. Adjuvant treatment strategies for endometrial cancer, such as external beam pelvic radiotherapy, vaginal brachytherapy, chemotherapy, and combined chemotherapy and radiotherapy, have been studied
Publikováno v:
International Journal of Gynecology & Obstetrics, 155, 45-60. WILEY
International Journal of Gynecology and Obstetrics, 155(S1), 45-60. Elsevier Ireland Ltd
International Journal of Gynecology and Obstetrics, 155(S1), 45-60. Elsevier Ireland Ltd
Endometrial cancer is the most common gynecological malignancy in high- and middle-income countries. Although the overall prognosis is relatively good, high-grade endometrial cancers have a tendency to recur. Recurrence needs to be prevented since th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::388ff806516d1da115080b80d7d63936
https://hdl.handle.net/1887/3278817
https://hdl.handle.net/1887/3278817
Autor:
Carien L. Creutzberg, Tjalling Bosse, Remi A. Nout, Elke E M Peters, Alicia Leon-Castillo, Claus Høgdall, Marie Boennelycke, Estrid Høgdall, Gitte Ørtoft, Vincent T.H.B.M. Smit
Publikováno v:
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists. 41(3)
Approximately 15% of patients with endometrial cancer present with high-risk disease (HREC). Moreover, assessing the extent of lymphovascular space invasion (LVSI) may provide prognostic insight among patients with HREC. The aim of this study was to
Autor:
Ina M. Jürgenliemk-Schulz, Ludy C.H.W. Lutgens, Marie Helene Baron, V. Do, Karen W Verhoeven-Adema, C. Post, Nelleke Ottevanger, Carien L. Creutzberg, Christine Haie-Meder, Jonathan A. Ledermann, Susan Brooks, Geraldine Goss, Linda Mileshkin, Anthony Fyles, Paul Bessette, Melanie E Powell, Roldano Fossati, Mary McCormack, Stephanie M. de Boer, Henry C Kitchener, Andrea Lissoni, Alexandra Leary, Vincent T.H.B.M. Smit, Romerai D'Amico, Amanda Feeney, Dionyssios Katsaros, Remi A. Nout, Hans W. Nijman, Hein Putter, Prafull Ghatage, Pearly Khaw
Publikováno v:
International Journal of Radiation Oncology-Biology-Physics, 109(4), 975-986. ELSEVIER SCIENCE INC
International Journal of Radiation Oncology, Biology, Physics, 109, 975-986
International Journal of Radiation Oncology Biology Physics, 109(4), 975-986. Elsevier Science
International Journal of Radiation Oncology, Biology, Physics, 109(4), 975-986. ELSEVIER SCIENCE INC
International Journal of Radiation Oncology, Biology, Physics, 109, 4, pp. 975-986
International journal of radiation oncology, biology, physics, 109(4), 975-986. Elsevier
International Journal of Radiation Oncology, Biology, Physics, 109, 975-986
International Journal of Radiation Oncology Biology Physics, 109(4), 975-986. Elsevier Science
International Journal of Radiation Oncology, Biology, Physics, 109(4), 975-986. ELSEVIER SCIENCE INC
International Journal of Radiation Oncology, Biology, Physics, 109, 4, pp. 975-986
International journal of radiation oncology, biology, physics, 109(4), 975-986. Elsevier
Contains fulltext : 232064.pdf (Publisher’s version ) (Open Access) PURPOSE: The survival results of the PORTEC-3 trial showed a significant improvement in both overall and failure-free survival with chemoradiation therapy versus pelvic radiation t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2798f409593ab83be7f21b7d7f100a58
http://www.redjournal.org/article/S0360301620344473/pdf
http://www.redjournal.org/article/S0360301620344473/pdf